Bioceres, a fully-integrated global provider of crop productivity solutions, announced that its subsidiary Rizobacter Argentina has completed a $26 million public offering of Series V corporate bonds in the Argentine market.
The bonds were issued in two tranches: Class A: $5.2 million with maturity in March 2022 and an annual nominal interest rate of 0.98%; and Class B: $20. 8 million with maturity in March 2024 and an annual nominal interest rate of 5.5%.
Proceeds will be used to support working capital, extend debt maturities, and reduce financing costs, as well as for general corporate purposes.
Mr. Enrique Lopez Lecube, Chief Financial Officer of Bioceres, said: “This issuance is aligned with our overall strategy to further stabilize debt structure by extending maturities, and to continue strengthening our liquidity position. With this transaction we also secured working capital requirements to continue advancing our HB4 Program efforts, as well as expanding the global footprint of our key biological products. Moreover, it is encouraging to see the continued support and strong demand from investors for these follow-on public offerings thus demonstrating the confidence in Bioceres’ commercial progress and our disruptive crop productivity technology platform,” concluded Lopez Lecube.
Bioceres Crop Solutions is a fully integrated global provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality. To do this, Bioceres’ solutions create economic incentives for farmers and other stakeholders to adopt environmentally friendlier production practices.
The Company has a unique biotech platform with high-impact, patented technologies for seeds and microbial ag-inputs, as well as next generation crop nutrition and protection solutions. Through its HB4 program, the Company is bringing digital solutions to support growers’ decisions and provide end-to-end traceability for production outputs. For more information, click here.